Advertisement

Topics

A drug that inhibits the Notch signalling process is active in a range of advanced cancers

13:53 EST 1 Dec 2016 | Medical Xpress

Munich, Germany: A new anti-cancer drug that inhibits a key cell signalling process involved in many different cancers has shown that it is capable of stopping the progression of cancer and shrinking tumours. Importantly, it has been able to do this in rare cancers that are less well-studied such as adenoid cystic carcinoma.

Original Article: A drug that inhibits the Notch signalling process is active in a range of advanced cancers

NEXT ARTICLE

More From BioPortfolio on "A drug that inhibits the Notch signalling process is active in a range of advanced cancers"

Quick Search
Advertisement
 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...